View in EDS HTML Full Text PDF Full Text

Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation.

Saved in:
Bibliographic Details
Title: Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation.
Authors: Chin S; Department of Gastroenterology, Royal Prince Alfred Hospital, Sydney, Australia.; Department of Gastroenterology, Austin Health, Melbourne, Australia., Con D; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia., Hilley P; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia., Corte C; Department of Gastroenterology, Royal Prince Alfred Hospital, Sydney, Australia.; University of Sydney, Sydney, Australia., Liu K; Department of Gastroenterology, Royal Prince Alfred Hospital, Sydney, Australia.; University of Sydney, Sydney, Australia., Testro A; Department of Gastroenterology, Austin Health, Melbourne, Australia.; The Australian Centre for Transplantation Excellence and Research, Austin Health, Melbourne, Australia.; The Department of Surgery (Austin Precinct), The University of Melbourne, Melbourne, Australia., De Cruz P; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia., Choy MC; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia., Srinivasan A; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia.; Eastern Health Clinical School, Monash University, Clayton, Australia.
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2025 Nov; Vol. 62 (10), pp. 1003-1011. Date of Electronic Publication: 2025 Jul 15.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40663036
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chin+S%22">Chin S</searchLink>; Department of Gastroenterology, Royal Prince Alfred Hospital, Sydney, Australia.; Department of Gastroenterology, Austin Health, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Con+D%22">Con D</searchLink>; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Hilley+P%22">Hilley P</searchLink>; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Corte+C%22">Corte C</searchLink>; Department of Gastroenterology, Royal Prince Alfred Hospital, Sydney, Australia.; University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Liu+K%22">Liu K</searchLink>; Department of Gastroenterology, Royal Prince Alfred Hospital, Sydney, Australia.; University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Testro+A%22">Testro A</searchLink>; Department of Gastroenterology, Austin Health, Melbourne, Australia.; The Australian Centre for Transplantation Excellence and Research, Austin Health, Melbourne, Australia.; The Department of Surgery (Austin Precinct), The University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22De+Cruz+P%22">De Cruz P</searchLink>; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Choy+MC%22">Choy MC</searchLink>; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Srinivasan+A%22">Srinivasan A</searchLink>; Department of Gastroenterology, Austin Health, Melbourne, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia.; Eastern Health Clinical School, Monash University, Clayton, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228707234%22">Alimentary pharmacology & therapeutics</searchLink> [Aliment Pharmacol Ther] 2025 Nov; Vol. 62 (10), pp. 1003-1011. <i>Date of Electronic Publication: </i>2025 Jul 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8707234 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2036 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202692813%22">02692813 </searchLink><i>NLM ISO Abbreviation: </i>Aliment Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40663036
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/apt.70283
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1003
    Titles:
      – TitleFull: Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chin S
      – PersonEntity:
          Name:
            NameFull: Con D
      – PersonEntity:
          Name:
            NameFull: Hilley P
      – PersonEntity:
          Name:
            NameFull: Corte C
      – PersonEntity:
          Name:
            NameFull: Liu K
      – PersonEntity:
          Name:
            NameFull: Testro A
      – PersonEntity:
          Name:
            NameFull: De Cruz P
      – PersonEntity:
          Name:
            NameFull: Choy MC
      – PersonEntity:
          Name:
            NameFull: Srinivasan A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2036
          Numbering:
            – Type: volume
              Value: 62
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Alimentary pharmacology & therapeutics
              Type: main
ResultId 1